Multiple Roles for the Major Histocompatibility Complex Class I- Related Receptor FcRn
Multiple functions have recently been identified for the neonatal Fc receptor FcRn. In addition, a human homolog of the rodent forms of FcRn has been identified and characterized. This major histocompatibility complex class I-related receptor plays a role in the passive delivery of immunoglobulin (I...
Gespeichert in:
Veröffentlicht in: | Annual review of immunology 2000-01, Vol.18 (1), p.739-766 |
---|---|
Hauptverfasser: | , |
Format: | Artikel |
Sprache: | eng |
Schlagworte: | |
Online-Zugang: | Volltext |
Tags: |
Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
|
Zusammenfassung: | Multiple functions have recently been identified for the neonatal Fc
receptor FcRn. In addition, a human homolog of the rodent forms of FcRn has
been identified and characterized. This major histocompatibility complex class
I-related receptor plays a role in the passive delivery of immunoglobulin
(Ig)Gs from mother to young and the regulation of serum IgG levels. In
addition, FcRn expression in tissues such as liver, mammary gland, and adult
intestine suggests that it may modulate IgG transport at these sites. These
diverse functions are apparently brought about by the ability of FcRn to bind
IgGs and transport them within and across cells. However, the molecular details
as to how FcRn traffics within cells have yet to be fully understood, although
in vitro systems have been developed for this purpose. The molecular nature of
the FcRn-IgG interaction has been studied extensively and encompasses residues
located at the CH2-CH3 domain interface of the Fc region of IgG. These Fc amino
acids are highly conserved in rodents and man and interact with residues
primarily located on the 2 domain of FcRn. Thus, it is now possible to
engineer IgGs with altered affinities for FcRn, and this has relevance to the
modulation of IgG serum half-life and maternofetal IgG transport for
therapeutic applications. |
---|---|
ISSN: | 0732-0582 1545-3278 |
DOI: | 10.1146/annurev.immunol.18.1.739 |